Commercial Moderna builds commercial muscle as new launches loom PharmaphorumModerna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.Read full story pharminent June 17, 2026 (Last updated: June 17, 2026) Pharmaphorum Moderna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow. Read full story Post navigation Previous: Altaris to acquire Simulations Plus in $375m all-cash dealNext: Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Related Stories Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026 Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026
